- The new Tamper-evident Seal portfolio comprises a range of materials all secured by the S799P adhesive that offers superior performance on most varnished cardboard, making it harder to interfere with cartons and enabling easier compliance with the imminent EU Medicine Directive. This is designed to prevent “falsified medicines” entering the legal supply chain that applies to all prescription and some OTC medicinal products, requiring outer packaging to reveal any tampering, from February 2019 onwards.
- TT Sensor Plus™ 2 is a ‘smart label’ that records time and temperature data on temperature-sensitive products, such as pharmaceuticals, biotech medicines and vaccines. It also provides a complete solution with multiple services such as a cloud environment, computer software, a mobile APP, and an application programming interface (API). Data are stored in a near field communication (NFC) chip and can be uploaded to the cloud via a smartphone or a computer at anytime, anywhere throughout the supply chain. When affixed to a product or container, TT Sensor Plus™ 2 can be programmed by the user to record the temperature history of goods at defined intervals during shipment.
- Avery Dennison S717P emulsion acrylic adhesive technology provides an effective solution to reduce ‘label lift’ on challenging pharma applications, such as plastic/treated glass syringes, and vials, where low energy surfaces and/or small diameters place enormous demands on the label. S717P also offers a rapid recertification process. The ‘P’ suffix indicates it is part of Avery Dennison’s dedicated pharma range, maintained as a stable product with formal change management control with 12 months notification times in place where changes have to be made. Certificates are in place for migration, toxicology and food applications, reducing re-qualification costs by around 20-30% compared with a start-from-scratch approval process with standard syringe labeling, thus speeding up re-certification.
Falsified Medicines Directive priority
“With the EU’s new Falsified Medicines Directive 2011/62 EU due to come into force a year from now, tamper-evidence on packaging and supply chain security have become front-of-mind issues for Pharma manufacturers and end users,” commented Gabriela Gregor, Avery Dennison Product Manager Pharmaceuticals Europe.
“At Pharmapack, we will be showing solutions to the more complex challenges of providing secure labeling and sealing on challenging shapes and surfaces, along with greater control over cool-chain logistics,” said Ms. Gregor.
“Visitors to our stand will be able to get hands-on with our new labeling ranges as well as see temperature and monitoring in real time via TT Sensor Plus™ 2 linked to mobile platforms,” she added.